Priyam Shah | Head, Investor Relations |
Brian McKelligon | Chief Executive Officer |
Joe Driscoll | Chief Financial Officer |
John Sourbeer | UBS |
Kyle Mikson | Canaccord |
Mason Carrico | Stephens |
Tejas Savant | Morgan Stanley |
Mark Massaro | BTIG |
David Westenberg | Piper Sandler |
Tim Chiang | Capital One |
Thank you for standing by. And welcome to the Akoya Biosciences Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]